CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 84 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2018. The put-call ratio across all filers is 3.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $628,000 | -32.8% | 128,926 | -4.4% | 0.01% | -28.6% |
| Q2 2019 | $935,000 | -11.0% | 134,917 | -10.8% | 0.01% | 0.0% |
| Q1 2019 | $1,051,000 | +36.1% | 151,292 | +14.4% | 0.01% | +16.7% |
| Q4 2018 | $772,000 | +1.0% | 132,272 | +30.7% | 0.01% | +20.0% |
| Q3 2018 | $764,000 | +82.3% | 101,232 | +22.1% | 0.01% | +66.7% |
| Q2 2018 | $419,000 | +18.4% | 82,927 | +67.7% | 0.00% | 0.0% |
| Q3 2017 | $354,000 | +23.8% | 49,457 | +9.1% | 0.00% | +50.0% |
| Q2 2017 | $286,000 | – | 45,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |